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ABSTRACT. Objective. The anaesthetic conserving device
(AnaConDa
 , Sedana Medical, Sundbyberg, Sweden)
facilitates administration of isoﬂurane or sevoﬂurane by liquid
infusion. An anaesthetic reﬂector inside the device conserves
exhaled anaesthetic and re-supplies it during inspiration. In this
bench study, we examined the inﬂuence of infusion rates and
ventilatory settings on the resulting anaesthetic concentrations
on patient (Cpat) and ventilator side of the reﬂector (Closs)t o
describe its technical performance. Methods. A Puritan
Bennett 840 ICU ventilator (Pleasanton, US), AnaConDa
 ,
and a test lung (3 l-chloroprene-bag) were assembled. Infusion
rates (IR, 0.2–50 ml h
-1), respiratory rates (RR, 5–40 breaths
min
-1), and tidal volumes (VT, 0.3, 0.5, and 1.0 l) were varied.
Cpat was measured via a thin catheter in the middle of the 3 l-bag
in steady state (online data storage and averaging over >10 min).
Closs was calculated from IR (to yield the volume of vapour per
unit of time), and expired minute volume (inwhich the vapour is
diluted)ontheassumptionthat,inthesteadystate,inputbyliquid
infusion equals output through the reﬂector. Results. Atlower
concentrations (Cpat<1 vol%) the ratio Closs/Cpat was constant
(RC =0 . 0 9 6±0.012) for all combinations of IR, RR and VT,
both for isoﬂurane and sevoﬂurane. The device could efﬁciently
reﬂect up to 10 ml vapour per breath (e.g. 2 vol% in 0.5 l). When
exceeding this capacity, surplus vapour ‘‘spilled over’’ and RC
markedly increased indicating decreased performance.
Conclusions. The triple product minute volume times RC
timesCpatdescribesanaestheticlossesthroughthereﬂector.Itcan
easily be calculated as long as the 10 ml reﬂection capacity is not
exceeded and thus RC is constant. Increased minute ventilation
necessitates increasing the IR to keep Cpat constant. When using
large VTand highCpat‘‘spillover’’occurs. Thiseffectofferssome
protection against an inadvertent overdose.
KEY WORDS. anaesthetic conserving device, isoﬂurane, sevo-
ﬂurane, ICU, sedation.
List of abbreviations: ACD – anaesthetic conserving device; Cl
– clearance; Closs – mean anaesthetic concentration on the
ventilator side of the reﬂector; Cpat – mean anaesthetic
concentration in the test lung; CS – circle system; F – factor
for calculating the volume of anaesthetic vapour from liquid
anaesthetic; FGF – fresh gas ﬂow; ICU – intensive care unit;
MV – minute ventilation; IR – infusion pump rate (of the
syringe pump); RC – ratio of the anaesthetic concentrations
on both sides of the reﬂector (Closs/Cpat); RR – respiratory
rate; VT – tidal volume; V¢delivered – volume of anaesthetic
vapour delivered per unit of time; V¢loss – volume of
anaesthetic vapour lost through the reﬂector per unit of time
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The anaesthetic conserving device (ACD) AnaConDa
 
(Sedana Medical, Sundbyberg, Sweden) facilitates the
administration of isoﬂurane or sevoﬂurane using con-
ventional ventilators avoiding circle systems, vaporizers
and soda lime. Its clinical use for anaesthesia has ﬁrst been
described by Enlund et al. [1], whereas Sackey et al. [2]
reported its safe use for inhalational sedation in the
intensive care unit (ICU). The device has been licensed in
the European Union and Canada and is increasingly used
for ICU sedation [3–5]. It is crucial to understand the
principles of operation to become aware of pitfalls and
achieve correct dosing of anaesthetics as the use of the
ACD has little in common with the conventional
vaporizer—circle system technique, the closed anaesthesia
system or the dosing regimen of intravenous drugs.
Therefore even for anaesthetists, the new method of
application and its dependencies may be difﬁcult to
understand. When introducing the method into clinical
practice, gas monitoring and some sort of gas scavenging
must be available, and all staff involved must be properly
trained. Some pitfalls and proper handling of the device
have been described by our group [6].
A crucial ACD component is the anaesthetic reﬂector
consisting of activated charcoal ﬁbres. It conserves exhaled
anaesthetic and re-supplies it during inspiration. This is
similar to a heat moisture exchanger reﬂecting water
vapour. However, in addition to reﬂecting, the ACD must
also deliver anaesthetic. Therefore liquid anaesthetic is
infused by a syringe pump into a porous rod called an
evaporator. Evaporated anaesthetic in combination with
reﬂected anaesthetic becomes the total inhaled anaesthetic.
It was the purpose of this bench study to determine the
inﬂuence of both anaesthetic delivery and ventilatory
settings on the concentrations of isoﬂurane and sevoﬂu-
rane in a test lung. By comparing these with the corre-
sponding concentrations on the ventilator side of the
device we describe the technical performance of the
reﬂector in a calculation model.
METHODS AND MATERIALS
Experimental setup
A Puritan Bennett 840 ICU ventilator (Pleasanton,
California, USA) was set up and checked according to the
manufacturer’s instructions. In the performance veriﬁca-
tion test, the inaccuracy of volume measurement was
determined to be below 10% for all calibration volumes
(0.025, 0.2, 0.6 and 2.5 l). The ventilator compensates
volume measurement for body temperature pressure sat-
urated conditions as well as for the compliance of hoses
that was determined to be 2.27 ml cm H2O
-1 in the
short self test. Leakage was negligible. An anaesthesia gas
scavenging system with reservoir (AGS 33 300, Dra ¨ger
Medical, Lu ¨beck, Germany) was connected to the expi-
ratory port of the ventilator to avoid contamination of the
workplace.
Y-piece, ACD, a catheter mount with a bronchoscopy
port and a 3 l chloroprene bag for manual ventilation
from an anaesthesia machine (Dra ¨ger Medical) were
assembled in line, the latter serving as a test lung
(Figure 1). Through the bronchoscopy port a thin cath-
eter was inserted into the test lung for side stream gas
monitoring with the monitor Vamos
  (Dra ¨ger Medical)
at a sampling rate of 0.15 l min
-1. The sample gas was
returned to the patient side of the ACD through the port
intended for gas sampling. All materials used were for
single use and had never been in contact with volatile
anaesthetics except the ventilator, the test lung and the gas
monitor.
Liquid isoﬂurane or sevoﬂurane (Abbott Laboratories,
Illinois, USA) were ﬁlled into a special syringe from the
bottle using the appropriate adapter (Sedana Medical) in a
separate room to avoid air pollution. The syringe (Sedana
Medical), made of special material inert to the agents used,
was ﬁtted into a syringe pump before connecting it to the
infusion line of the ACD. The syringe pump (Ivac
 ,
Cardinal Health—Alaris Products, Dublin, Ohio, USA)
adjusted for Becton Dickinson Plastipak syringes with a
high cut off pressure (120 kPa) was installed on a constant
3
6
7
8
9
4
2
11
10
16
1
5
13
12
15
Cpat Cpat
Closs Closs
MV
MV
14
Fig. 1. Experimental setup. (1) Anaesthesia gas scavenging, (2) ICU
ventilator, (3) inspiratory hose, (4) expiratory hose, (5) Y-piece,
(6) anaesthetic conserving device, (7) catheter mount (with bronchoscopy
port), (8) test lung (3 l chloroprene bag), (9) thin catheter, (10) gas sam-
pling tube, (11) gas monitor, (12) redelivery of sample gas, (13) serial
communication cable, (14) notebook computer for online data sampling,
(15) syringe pump (16) syringe ﬁlled with liquid isoﬂurane or sevoﬂurane.
MV expiratory minute ventilation, carrying anaesthetic vapour through the
anaesthetic reﬂector. Closs mean anaesthetic concentration in the gas expired
through the anaesthetic reﬂector. Cpat mean anaesthetic concentration inside
the 3 l bag under steady state conditions.
12 Journal of Clinical Monitoring and Computinglevel below the ACD to avoid gravity effects as described
by Berton et al. [7] and our group [6].
Respiratory rates (RR), tidal volumes (VT) and infu-
sion pump rates (IR) were varied. RR were 5, 10, 20, and
40 breaths min
-1,V T 0.3, 0.5, and 1.0 l, and IR were
3.33, 8.33, 16.6, 33.3, 83.3, 166.6, and 833.3910
-6
l min
-1 (0.2, 0.5, 1.0, 2.0, 5.0, 10.0, and 50.0 ml h
-1).
For experiments with VT of 0.3 and 1.0 l, only a RR of 10
breaths min
-1 was used. We used constant inspiratory ﬂow
at 33% of total cycle time, no inspiratory hold, an oxygen
concentration of 21 vol% and a positive end expiratory
pressure of 3 cm H2O to keep the test lung inﬂated.
Calculation of Closs
In our bench model we calculated the mean anaesthetic
concentration on the ventilator side of the reﬂector (Closs).
Under steady state conditions, conﬁrmed by the stability
of the concentration in the test lung, all anaesthetic
delivered into the system per unit of time (V¢delivered) must
escape the system. The anaesthetic vapour cannot diffuse
through the test lung because chloroprene is impermeable
to volatile anaesthetics. Air leaks have been excluded
during the setup of the method. Therefore the only way
for anaesthetic vapour to escape the system is through the
anaesthetic reﬂector that will reﬂect most, but not all
anaesthetic molecules. Anaesthetic molecules reaching the
ventilator side of the reﬂector will be ﬂushed away,
diluted in the unsteady ﬂow of the expired minute vol-
ume. Closs can thus be calculated as follows:
Closs ¼
V0
delivered
MV
  100 ¼
IR   F
RR   VT
  100 vol% ðÞ ð 1Þ
MV is the expired minute ventilation. F is the factor for
calculating anaesthetic vapour from liquid anaesthetic:
Using the ideal gas law, Avogadro’s law and the physical
density of liquid isoﬂurane/sevoﬂurane, F can be calcu-
lated as 219.1 and 207.6 ml vapour per ml liquid anaes-
thetic under body temperature pressure saturated
conditions for isoﬂurane and sevoﬂurane, respectively.
Measurement of Cpat
The mean anaesthetic concentration in the middle of the
test lung in steady state was called ‘‘patient concentration’’
(Cpat). For all combinations of RR, VT and IR, both for
isoﬂurane and for sevoﬂurane, experiments were per-
formed twice: We expected Cpat to be related to Closs.
Therefore the experiments were arranged in such an order
that Closs, calculated in advance, was ﬁrst increasing, and
then decreasing. This was done to reach the steady state
earlier and to avoid a possible carry over effect by the
volatile anaesthetic dissolving in and being released from
the materials used. The measurements of Cpat from the in-
and decreasing series were ﬁnally averaged.
Gas measurements displayed to the second decimal
place were stored online on a notebook computer once
every second with the data sampling program Visia
 
provided by the gas monitor’s manufacturer. For each
experiment, data were sampled over a period of at least
30 min. The stability of the measured Cpat was conﬁrmed
visually by looking at a trend diagram. Only if a stable
plateau was reached and maintained for at least 10 min,
data from this plateau were averaged. The gas monitor
Vamos
  calibrates itself automatically every 2 h. We used
two gas monitors of the same model and frequent
exchanges did never result in different readings.
To describe the technical performance of the reﬂector,
the ratio of Closs to Cpat was calculated (RC = Closs/Cpat).
Data are presented as mean (SD). For comparison of RC
for isoﬂurane and sevoﬂurane Student’s t test for paired
samples was used.
RESULTS
Table 1 presents the measured values of Cpat and the ratio
of the concentrations on both sides of the reﬂector
(RC = Closs/Cpat) at the different IR and ventilatory set-
tings. Six settings yielding Cpat outside the measurement
range of the gas monitor (4<0.1 vol%, 2>11 vol%)
had to be discarded in the isoﬂurane and sevoﬂurane series
(Table 1).
In Figure 2a and b the calculated Closs is plotted against
the measured Cpat for isoﬂurane and sevoﬂurane, respec-
tively. At lower concentrations (Cpat £ 1 vol%) there is a
linear relationship between Closs and Cpat independent of
the ventilatory settings. At higher concentrations all
curves bend upwards. In the isoﬂurane (sevoﬂurane)
diagram the curve for the large VT of 1.0 l starts bending
upwards between 0.77 and 1.42 vol% (0.69–1.31 vol%),
the curve for the small VT of 0.3 l bends upwards between
2.30 and 4.44 vol% (2.17–4.06 vol%). The four curves
with the middle VT of 0.5 l, but with differing RR, all
bend upwards around 2 vol%. Thus the RR shows little
inﬂuence on the progression of the curves. Exponential
regression lines do not give good ﬁts because in the lower
concentration range all curves seem exactly linear.
RC describes the slopes of the ﬁrst linear parts of all
curves. For these parts, until RC increases by more than
20% of the previous value (bold values Table 1), all values
of RC were averaged to yield 0.097 (0.014) for isoﬂurane
and 0.096 (0.012) for sevoﬂurane. The small difference
between the two is neither statistically nor clinically
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14 Journal of Clinical Monitoring and Computingsigniﬁcant. Therefore the total average was calculated as
0.096 (0.012), or as a reciprocal value: one to 10.4.
DISCUSSION
It is the main ﬁnding of our study that the ratio of the
anaesthetic concentrations on both sides of the anaesthetic
reﬂector is constant with a value of 0.096 (0.012):
RC ¼
Closs
Cpat
¼ 0:096 dimensionless ðÞ ð 2Þ
This technical performance is veriﬁable with different
ventilatory settings, both for isoﬂurane and sevoﬂurane,
and over the clinically used concentration range. In detail,
constant concentrations measured for Cpat were 10.4
times higher than Closs.
If we imagine that the anaesthetic reﬂector would not
work at all, Cpat would equal Closs and the data points in
Figure 2a and b would lie on the bisecting line. In a
similar bench experiment, Berton et al. [7] removed the
reﬂector from the device and the concentrations measured
on the patient side (0.1–0.4 vol%) were very close to our
calculation for Closs (Equation 1).
Another important ﬁnding of our study is that, when
the volume of anaesthetic vapour expired in one breath
exceeds 10 ml (Cpat9VT; e.g. 1 vol%91.0 l, 2 vol%9
0.5 l or 3.33 vol%90.3 l), Closs increases dispropor-
tionately. This may be interpreted as a ‘‘spill over’’: If
during expiration the maximal capacity of the reﬂector is
reached, no more anaesthetic molecules can be bound and
they will be carried through the reﬂector and be lost for
the patient. This ‘‘spill over effect’’ depends on the
number of molecules contained in the expired VT.
When using the ACD in clinical practice, one of the ﬁrst
questions arising is how to dose the anaesthetic to yield the
desired ‘‘patient concentration’’ (Cpat). By combining
Equations 1 and 2,C pat can easily be calculated as:
Cpat ¼
Closs
RC
¼
IR
RR   VT
 
F
RC
  100 vol% ðÞ ð 3Þ
For ICU sedation, usually 0.3–0.6 vol% isoﬂurane or
0.5–1.0 vol% sevoﬂurane are targeted. In this concentra-
tion range, RC will be constant. Therefore, in our bench
model, Cpat will be proportional to the infusion rate and
inversely proportional to the minute volume. RR and VT
have an equal inﬂuence.
In their bench study, Berton et al. [7] examined iso-
ﬂurane (F = 219.1 ml vapour per ml liquid anaesthetic) at
an IR of 5 ml h
-1, a rate commonly used in clinical
practice. But because of the lack of patient uptake, this
resulted in unusually high ‘‘patient concentrations’’ pro-
voking spill over. According to Equation 3,a nI Ro f
5m lh
-1 (83.3910
-6 l min
-1), a RR of 12 breaths
min
-1, and a VT of 0.3 l yields 5.2 vol%. This means that
one expired breath would contain 15.7 ml anaesthetic
vapour, which exceeds the capacity of the reﬂector. But
the authors measured a concentration of only 3.4 vol%
which corresponds to 10.2 ml isoﬂurane vapour con-
tained in one breath. When measuring in the range where
spill over occurs, the reﬂector seems to behave irregularly
and the authors were not able to construct a simple model
for calculation of Cpat such as the one presented here.
How can the ACD be compared to the classical circle
system (CS)? During anaesthesia, anaesthetic vapour has to
be delivered continuously to compensate ﬁrstly for patient
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Fig. 2. (a) and (b) Characteristic curves of AnaConDa
  for isoﬂurane (a)
and sevoﬂurane (b) with different ventilatory settings. The mean anaesthetic
concentrations on the ventilator side of the anaesthetic reﬂector (Closs,
[vol%]) plotted against the mean anaesthetic concentrations in the test lung
(Cpat, [vol%]). RR respiratory rates, VT tidal volumes. Each curve
describes a different ventilatory setting, each point a different infusion pump
rate. The straight line delineates a concentration ratio Closs/Cpat of 0.097
(isoﬂurane) and 0.096 (sevoﬂurane) respectively.
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tracheal suctioning or disconnections from the ventilator,
and thirdly for losses that occur during the normal oper-
ating of the system. Let us assume there are no patient
uptake and no leaks as in our bench test and look only at
anaesthetic losses inherent to the respective systems (V¢loss):
In the CS, a speciﬁed fresh gas ﬂow (FGF) enters the
system on one side (Figure 3, left). In the absence of
patient uptake and leaks, the outﬂow from the CS equals
the FGF and the anaesthetic concentrations in fresh gas,
inspired and expired air will all be the same after wash in
(CCS). Losses of anaesthetic vapour can be described as
(CCS should be inserted as a dimensionless fraction):
V0
loss;CS ¼ FGF   CCS lmin 1 
ð4Þ
With the ACD anaesthetic losses can be described by the
product MV times Closs (Figure 3, right). In the lower
concentration range we can replace Closs by inserting
Equation 2 (Cpat should be inserted as a dimensionless
fraction):
V0
loss;ACD ¼ MV   RC   Cpat lmin 1 
ð5Þ
The product MV times RC corresponds to the FGF of a
CS and both may be called clearance (Cl):
ClACD ¼ RC   MV ¼
Closs
Cpat
  MV lmin 1 
ð6Þ
This clearance of anaesthetic vapour through the reﬂector
is in many respects analogous to the clearance of creati-
nine by the kidneys, which can be calculated as the ratio
of the creatinine concentration in urine and plasma times
the ﬂow of urine. In the case of creatinine, the clearance
corresponds to the glomerular ﬁltration rate or the ﬂow of
primary urine. For most solutes, the clearance by the
kidney does not correspond to any real ﬂow, but can be
imagined as the ﬂow of an imaginary medium carrying the
solute out of the body.
Whereas a good renal function is witnessed by a high
clearance of solutes, a well performing ACD will be
characterized by a low clearance of the anaesthetic vapour.
Also in the case of the ACD the clearance may be
imagined as a ﬂow: If the ACD is performing well, Closs
will be much lower than Cpat and the clearance will be a
fraction (RC) of the minute ventilation. This fraction of
the minute ventilation can be imagined to ﬂush the system
and carry the anaesthetic vapour away, comparable to the
FGF ﬂushing the CS.
There still remains one important difference between
CS and ACD: Increasing the FGF will increase V¢loss. But
at the same time the vaporizer will deliver a larger volume
of vapour per unit of time, leaving the concentrations
unchanged. With the ACD, when the MV, and thus the
clearance ﬂow, is increased, the syringe pump will not
deliver any more anaesthetic automatically and therefore
the IR has to be adjusted manually.
syringe pump
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V
Comparing the performance
AnaConDa® Circle system
FGF V M V M F G F
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Closs
MV
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loss ∗ =
CCS
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Fig. 3. Comparison of the circle system (CS) with the Anaesthetic Conserving Device (ACD). A classical anaesthesia machine consists of the fresh gas supply
with the interposed vaporizer, the CS with soda lime, and a ventilator usually in form of a bag in bottle system. In the absence of patient uptake and leaks, the
outﬂow from the CS equals the FGF and the anaesthetic concentrations in fresh gas, inspired and expired air will all be the same after wash in (CCS). Losses
of anaesthetic vapour can be described as the product FGF times CCS. With the ACD, the anaesthetic is delivered as a liquid via a syringe pump. Closs, the
mean concentration on the ventilator side of the device, is 10.4 times lower than Cpat. Vapour losses can be calculated as the product minute ventilation (MV)
times Closs. Vapour losses can also be imagined to be carried away by a clearance ﬂow ﬂushing the patient side of the ACD (semicircular arrow). The clearance
is a fraction (Closs/Cpat = 0.097) of the minute volume. Vapour losses can be calculated as the product clearance times Cpat.
16 Journal of Clinical Monitoring and ComputingWe chose to calculate Closs instead of measure it, as we
expected Closs to be ten times smaller than Cpat and
therefore out of the measurement range of our gas
monitor in half of the experiments performed. Unlike
Cpat,C loss is not a stable concentration, but is ﬂuctuating,
and it would have been necessary to average Closs over the
expiratory ﬂow. Measuring the expiratory ﬂow and
combining the two measurements would have increased
the total error. On the other hand our calculation is
straight forward. Even if the assumption that all materials
on the patient side of the reﬂector (catheter mount, chassis
of the AnaConDa
 ) are gastight and that all anaesthetic
delivered must be lost through the anaesthetic reﬂector,
may not be absolutely right, these materials are used in
clinical practice, and if anaesthetic agent is lost via these
routes our calculations focussing on anaesthetic losses
inherent to the ACD are valid.
We employed equipment commonly used in clinical
practice. According to the manufacturer’s speciﬁcations
the accuracy of the gas monitor is ±10%. Measuring
constant concentrations without tidal ﬂuctuations and in
the absence of water vapour should improve the accuracy.
Two gas monitors were used and frequent exchanges did
never result in different readings. In the calculation of
Closs, delivery of VT by the ventilator may be afﬂicted
with a maximum error of ±10% as well, whereas RR and
IR may be considered exact. For calculation of RC, with
maximum errors of ±10% in enumerator and denomi-
nator, total error can be estimated to be ±20% at the
most. But even if determination of RC may not be highly
accurate, it is important to denote that RC is constant in
the lower concentration range and dramatically increasing
once the capacity of the reﬂector is exceeded.
It was the aim of our study to describe the functioning
of the anaesthetic reﬂector as the more interesting and
more innovative component of the new device. For
several reasons we did not have a patient or experimental
animal to take up the anaesthetic. For the calculation of
Closs it was necessary to look at steady state conditions
without anaesthetic uptake as pointed out above. Our
bench model allowed us to measure Cpat as a stable
concentration in the middle of the test lung. To avoid
confusion we deliberately called that concentration
‘patient concentration’ and avoided the term ‘endtidal’. In
a patient study or in an animal model one would have to
consider alveolar, dead space, and mixed portions of the
expired tidal volume each with differing anaesthetic
concentrations. Last not least our bench model allowed us
to reduce the number of possible inﬂuencing and dis-
turbing factors and to concentrate on IR, RR and VT
with constant ﬂows. We were also able to apply extreme
conditions to get to the limits of the device, which would
not have been so easily possible in a patient or in an
animal model. Other factors that might inﬂuence the
performance of the reﬂector are temperature, humidity
and carbon dioxide. It is up to further studies to rule out
or quantify their respective inﬂuence.
A number of clinical studies compared anaesthetic
consumption with the ACD in a high ﬂow system to
conventional anaesthesia systems with speciﬁed FGFs.
Enlund, Wiklund and Lambert observed a 40% decrease
in isoﬂurane consumption compared to a high ﬂow
coaxial Bain system [1]. The same group found the con-
sumption of sevoﬂurane with the ACD to be similar to
the one in a circle system with a FGF of 1.5 l min
-1 [8].
Tempia and colleagues came to the same conclusion: they
found consumption of sevoﬂurane with the ACD in a half
open breathing circuit to be 6.2 ml h
-1. In the compar-
ison groups using circle systems with FGFs of 1.0, 1.5,
3.0, and 6.0 l min
-1, the consumption was 5.2, 6.2, 13
and 24 ml h
-1, respectively [9]. Assuming a MV of
5–10 l min
-1, the above deﬁned clearance would be
0.5–1.0 l min
-1. Therefore in theory the ACD should
perform slightly better than it turned out in practice.
Possible explanations to this fact might be the inclusion of
the priming volume contained in infusion line and
evaporator, which amounts to 1.3 ml liquid anaesthetic,
or possible spill over of volatile anaesthetic, when higher
concentrations for anaesthesia are used.
Sackey et al. [10] reported an average consumption of
only 2.1 ml h
-1 isoﬂurane to maintain Cpat at 0.5 vol%
during long term ICU sedation. According to the authors,
this was 4 times less compared to conventional high ﬂow
vaporizer systems. Assuming a minute ventilation of
10 l min
-1, the clearance would be 1 l min
-1 and V¢loss
can be calculated as 1.4 ml liquid anaesthetic per hour
(according to Equation 5 and after conversion to the
appropriate units). The sample gas lost for gas monitoring
accounts for another 0.2 ml h
-1. So only 0.5 ml h
-1
would be taken up by the patient, evaporate through the
skin or escape through leaks, e.g. during tracheal suc-
tioning.
Recently two studies evaluated the performance of
pharmacokinetic models in patients in the operating
theatre [11] and in the ICU [12]. This latter study eval-
uated the predictive performance of a simple pharmaco-
kinetic model for the manually adjusted infusion of
sevoﬂurane for use with the AnaConDa
 . The model
calculated patient uptake based on a nine compartment
model as well as losses through the ACD based on an
equation that gives very close results and shows a high
correlation with Equation 5. The study showed an
excellent predictive performance of the model in 50 pa-
tients for duration of up to 6 h.
We did not detect any differences between the two
volatile anaesthetics examined, neither concerning RC
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curves in Figure 2a, b), nor the range of high reﬂection
performance (up to the points, when the curves start
bending upwards). This is surprising considering the dif-
ferent physical characteristics of the two agents. As sevo-
ﬂurane is less potent, higher concentrations are needed
and thus spill over is more likely to occur. Our bench
study is descriptive in nature and minor differences
between the two volatile anaesthetics in the interaction
with the ACD cannot be ruled out. To our knowledge,
there is no published study examining differences in the
two agents to be used with the AnaConDa
 .
Drug dosing not only according to body weight or body
surface area but according to the MV is unusual for clini-
cians. When increasing the FGF, vaporizers will automat-
ically deliver a larger volume of anaesthetic vapour as
pointed out before. Only with low FGFs, when patient
uptake has a major inﬂuence on the resulting concentra-
tions, changes in FGF have to be met by changing the dial
of the vaporizer [13]. Using the ACD however, the IR has
to be adjusted, when the MV changes. But intensive care
physicians are not used to changing the infusion rate of a
drugwhenchangingthesettingsofaventilator.Inaddition,
theMVmaynotonlybechangedbythedoctor,butalsoby
the patient when breathing spontaneously. An increase in
MVwilllowertheconcentrationofthedrug,whichinturn
might increase respiratory drive. As a consequence, upper
and lower alarm limits for the MV should be set and the IR
adjusted accordingly.
With higher concentrations the reﬂection capacity may
be reached, especially when large tidal volumes are used.
The ‘‘spill over’’ of anaesthetic molecules may indeed
offer some protection against an inadvertent overdose: In
clinical practice, it may happen that the IR of sevoﬂurane
(isoﬂurane) erroneously is set at 50 instead of 5 ml h
-1.
With ventilatory settings of 1091.0 l min
-1, and
according to our bench model (Equation 3), Cpat instead
of the intended 1.7 vol% (1.8 vol%) would increase to
17 vol% (18 vol%), if no spill over would occur and RC
was constant over the whole concentration range. But in
fact, Cpat will only approach 3.9 vol% (3.6 vol%, see
Figure 2a, b; Table 1). If the same MV was applied with
the settings 2090.5 l min
-1, again not 17 but 5.6 vol%
(5.1 vol%) will be reached. But if small VT are used, the
spill over effect offers no protection and Cpat will be above
11 vol% (upper limit of the measurement range of the gas
monitor, see Table 1).
Therefore, a high performance of the reﬂector is not
the only important thing. One could speculate about
decreasing its capacity and by this narrow its range of high
performance. If Cpat increased, the clearance would
increase earlier and more anaesthetic vapour would escape
the system. This would further decrease the risk of over
dosage, also when small tidal volumes are used. By
reducing dead space, which in AnaConDa
  is 100 ml,
this as well would make the ACD more suitable for
children [14].
CONCLUSIONS
In this bench study, in the steady state, and at lower con-
centrations (£1 vol%), the ratio of the concentrations on
both sides of the anaesthetic reﬂector is constant at 0.096.
This is true for isoﬂurane and sevoﬂurane and for different
ventilatory settings. In other words, the anaesthetic con-
centration on thepatient side isabout tentimes higherthan
the concentration on the ventilator side. Both concentra-
tions are proportional to the infusion rate and inversely
proportional to the respiratory rate and the tidal volume.
Therefore in clinical practice, when the minute ventilation
is increased (lowered), the infusion rate should also be
increased (lowered) to keep the patient concentration
constant.
If the volume of vapour expired within one breath
exceeds 10 ml (Cpat9VT = 0.01 l; e.g. 1 vol%91.0 l,
2 vol%90.5 l, or 3.3 vol%90.3 l), the performance of
the reﬂector decreases, as molecules exceeding the
capacity of the reﬂector will be ﬂushed away. This ‘‘spill
over’’ effect may offer some protection against an inad-
vertent overdose.
In the lower concentration range, the clearance of
anaesthetic vapour can be calculated as the ratio of the
concentrations on both sides of the reﬂector (RC) times
the minute volume. This clearance corresponds to a fresh
gas ﬂow in a circle system between 0.5 and 1.5 l min
-1.
This has already been shown in clinical studies.
The study was carried out without third party funding. Abbott
Laboratories and Sedana Medical bore the expenses for publishing
this article with open access.
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